Search Results 1621-1630 of 14773 for anti-TNF drugs

1. Emtricitabine And Tenofovir Alafenamide (Oral Route) Description and Brand Names - Mayo Clinic

   Emtricitabine and tenofovir alafenamide combination is used together with other medicines to treat human immunodeficiency virus (HIV) infection. HIV is the ...

2. Pacritinib (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

3. Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients - Mayo Clinic

   ... anti-fibrotic and anti-remodeling drug as co-therapy during LVAD support. Participation eligibility. Participant eligibility includes age, gender, type and ...

4. A Study of Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) - Mayo Clinic

   ... therapy must be resolved to ≤ Grade 1 or clinical baseline. Participants who are receiving chronic nonsteroidal anti-inflammatory drugs (NSAIDs) as treatment ...

5. A Study of the Safety and Effectiveness of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution for Non-Infectious Anterior Uveitis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... anti-hypertensive medications in the study eye; Is a known steroid ...

6. Estradiol And Norethindrone (Transdermal Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Combipatch. Canadian Brand Name. Estalis ...

7. A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... anti-cancer therapy for 2 years 14. Pregnant or lactating. If ?-HCG is ...

8. A Study to Evaluate the Impact of a Pharmacist-led Oral Anticancer Medication (OAM) Program on Patient Outcomes - Mayo Clinic

   ... therapy. Exclusion Criteria: Any patient who had previously received oral anti-cancer (OAM) therapy. Patient age < 18 years. Pregnancy. Participating Mayo ...

9. A Study of the Combination of IMCgp100 with Durvalumab and/or Tremelimumab for Patients with Advanced Cutaneous Melanoma - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... therapy or in combination with anti-PD-1 therapy. Phase II IMT naive cohort.

10. Tenapanor (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Ibsrela; Xphozah. Descriptions. Tenapanor is used to treat ...